# Emergent Biosolutions Canada Inc.

Canonical: https://abierto.us/vendors/emergent-biosolutions-canada-inc-xm23stfmvml6

- UEI: XM23STFMVML6
- CAGE: L0EM2
- Parent: Emergent Biosolutions Inc.
- Location: Winnipeg, CAN
- Awards in window: 2 (15 transactions), $355,528,256 obligated, February 22, 2024 to May 27, 2026

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 2 awards, $355,528,256

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $355,528,256

## Competition

- Not Competed: 2 awards

## Largest awards

- 75A50119C00075 (definitive contract): $187,180,193, Aspr/Orm-Sns. EO14042 Botulism Antitoxin. https://www.usaspending.gov/award/CONT_AWD_75A50119C00075_7505_-NONE-_-NONE-/
- 75A50119C00037 (definitive contract): $168,348,063, Aspr/Orm-Sns. Vaccinia Immune Globulin Intravenous (Vig-Iv) Buy and Associated Services for Up to 10 Years.. https://www.usaspending.gov/award/CONT_AWD_75A50119C00037_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/emergent-biosolutions-canada-inc-xm23stfmvml6.